rotavin

Vaccineexperimental

Clinical trial activity

3 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
2
Phase 4
0

Earliest trial started Aug 1, 2009 (NCT01375907)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • RotavirusImmunity, active

    Rotavirus immunity, active

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • rotavin-m1

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03703336Phase 3Mar 31, 2019Center for Research and Production of Vaccines and Biologicals, Vietnam, Government of Vietnam, PATH, University of Cincinnati
NCT01502969Phase 2/Phase 3 (Phase 3)May 1, 2010Government of Vietnam, The National Institute of Hygiene and Epidemiology, Veitnam
NCT01375907Phase 1Aug 1, 2009Government of Vietnam
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of VietnamGovernment3222009
Center for Research and Production of Vaccines and Biologicals, VietnamAcademic/Hospital1112019
PATHAcademic/Hospital1012019
The National Institute of Hygiene and Epidemiology, VeitnamGovernment1012010
University of CincinnatiAcademic/Hospital1012019
5 organizations
Page 1 / 1